Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — update 2018
Yair Lotan(Southwestern Medical Center), Siamak Daneshmand(Unknown), Michael A. O’Donnell(University of Iowa Health Care), Tracy M. Downs(University of Wisconsin–Madison), Angela B. Smith(Communities In Schools of Orange County), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Per‐Uno Malmström(Uppsala University), Kamal S. Pohar(The Ohio State University), Gary D. Steinberg(Rush University Medical Center), William C. Huang(NYU Langone Health), Badrinath R. Konety(Allina Health), Michael Woods(University of Cambridge), Sanjay Patel(Oklahoma City University), Trinity J. Bivalacqua(University of Pennsylvania), Jeffrey A. Jones(Cleveland Clinic), Edouard J. Trabulsi(Thomas Jefferson University), Matthew J. Resnick(Vanderbilt University Medical Center), Alexander Sankin(Montefiore Medical Center)
Cited by 84
Related Papers
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660